Unique Ingredient Identifier K679OBS311 is listed as a unspecified ingredient
| RN | 9004-32-4 |
| NCIT | C83596 |
| RXCUI | 491498 |
UNII K679OBS311 CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INTRA-ARTICULAR | INJECTION | 0.75 % |
| INTRAMUSCULAR | INJECTION | 0.75 % |
| ORAL | TABLET, DELAYED RELEASE | 36 mg |
| ORAL | TABLET, EXTENDED RELEASE | 40 mg |
| ORAL | TABLET | 105 mg |
| DENTAL | GEL | 0.4 % |
| DENTAL | PASTE | 174 MG |
| ENTERAL | SUSPENSION | 29.2 MG/ML |
| IM - IV | INJECTION | NA |
| INTRA-ARTICULAR | INJECTABLE | 0.75 % |
| INTRA-ARTICULAR | INJECTION | 7.5 MG/1ML |
| INTRA-ARTICULAR | INJECTION | 0.76 % |
| INTRA-ARTICULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 25 MG |
| INTRA-ARTICULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRABURSAL | INJECTION | 0.76 % |
| INTRADERMAL | INJECTION | NA |
| INTRADERMAL | INJECTION, SUSTAINED ACTION | NA |
| INTRALESIONAL | INJECTION | NA |
| INTRALESIONAL | INJECTION, SUSTAINED ACTION | NA |
| INTRAMUSCULAR | INJECTABLE | 15 mg |
| INTRAMUSCULAR | INJECTABLE | 0.75 %W/V |
| INTRAMUSCULAR | INJECTION | 25 mg |
| INTRAMUSCULAR | INJECTION | 3 % |
| INTRAMUSCULAR | INJECTION, MICROSPHERES | 1 % |
| INTRAMUSCULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 3 % |
| INTRAMUSCULAR | POWDER, FOR INJECTION SUSPENSION | 0.7 %W/V |
| INTRASYNOVIAL | INJECTION | 0.1 % |
| INTRASYNOVIAL | INJECTION, SUSTAINED ACTION | NA |
| INTRATRACHEAL | SUSPENSION | NA |
| INTRAVITREAL | SUSPENSION, INJECTION | 0.5 % |
| NASAL | SPRAY, METERED | 0.15 % |
| OPHTHALMIC | SOLUTION | 0.5 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.5 % |
| ORAL | CAPSULE | 160 MG |
| ORAL | CAPSULE, DELAYED ACTION, COATED, HARD GELATIN | 4 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 4.2 MG |
| ORAL | CAPSULE, HARD GELATIN | NA |
| ORAL | CAPSULE, SUSTAINED ACTION | 0.47 MG |
| ORAL | DROPS | 12.85 MG/2.5ML |
| ORAL | GRANULE | 25.7 MG |
| ORAL | GRANULE, FOR SUSPENSION | NA |
| ORAL | POWDER, FOR ORAL SOLUTION | 4.2 MG |
| ORAL | POWDER, FOR SOLUTION | 2.63 MG/1ML |
| ORAL | POWDER, FOR SUSPENSION | 1 % |
| ORAL | SOLUTION | 35 MG |
| ORAL | SUSPENSION | 2000 MG/5ML |
| ORAL | SUSPENSION, DROPS | 2.5 MG/2.5ML |
| ORAL | SUSPENSION, SYRUP, SUSTAINED ACTION | 0.02 % |
| ORAL | SYRUP | 50 MG/5ML |
| ORAL | TABLET | 48 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 24.75 MG |
| ORAL | TABLET, COATED | 3.2 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 0.04 mg |
| ORAL | TABLET, DELAYED ACTION | 50 MG |
| ORAL | TABLET, EXTENDED RELEASE | 233.3 MG |
| ORAL | TABLET, FILM COATED | 50 MG |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 50.02 MG |
| ORAL | TABLET, SUSTAINED ACTION | 155 MG |
| SOFT TISSUE | INJECTION | 0.5 % |
| SUBCUTANEOUS | IMPLANT | 16 MG |
| SUBCUTANEOUS | INJECTION | NA |
| TOPICAL | FILM, CONTROLLED RELEASE | 700 MG |
| TOPICAL | JELLY | NA |
| TOPICAL | LOTION | NA |
| TOPICAL | PASTE | NA |
| TOPICAL | PASTE, DENTIFRICE | NA |
| TOPICAL | PATCH | 210 MG |
| TOPICAL | PATCH, CONTROLLED RELEASE | NA |
| TOPICAL | SOLUTION | 0.5 %W/W |
| VAGINAL | EMULSION, AEROSOL FOAM | 0.2 % |